Overall, our studies provided new mechanistic insights into GLP-1’s anti-obesity actions in which GLP-1 induces the secretion of FNDC5 derivatives from its responsive organs that then mediate its anti-obesity activities. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.